Supplementary Data 1 from Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti–PD-1–Resistant Advanced Melanoma

<p>Immunologic pathway genes</p>

Spremljeno u:

Bibliografski detalji
Glavni autor:	Alexander N. Shoushtari (15023909) (author)
Daljnji autori:	Anthony J. Olszanski (15031292) (author), Marta Nyakas (15051200) (author), Thomas J. Hornyak (15051203) (author), Jedd D. Wolchok (15032924) (author), Victor Levitsky (15051206) (author), Lukasz Kuryk (15051209) (author), Thomas B. Hansen (15051212) (author), Magnus Jäderberg (15051215) (author)
Izdano:	2025
Teme:	Cancer Tumor Biology Clinical Research and Trials Clinical-Stage Research Skin Cancers Melanoma Tumor Microenvironment Immune cells and the microenvironment
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!

Slični predmeti